Molchan SE - Search Results

1

Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease.

Sunderland T, Berrettini WH, Molchan SE, Lawlor BA, Martinez RA, Vitiello B, Tariot PN, Cohen RM. Sunderland T, et al. Among authors: molchan se. Biol Psychiatry. 1991 Jul 1;30(1):81-7. doi: 10.1016/0006-3223(91)90073-u. Biol Psychiatry. 1991. PMID: 1716470

2

A strategy of "combination chemotherapy" in Alzheimer's disease: rationale and preliminary results with physostigmine plus deprenyl.

Sunderland T, Molchan S, Lawlor B, Martinez R, Mellow A, Martinson H, Putnam K, Lalonde F. Sunderland T, et al. Int Psychogeriatr. 1992;4 Suppl 2:291-309. Int Psychogeriatr. 1992. PMID: 1288668 Clinical Trial.

3

Measurement and interpretation of changes in memory in response to drug treatments.

Weingartner H, Eckardt M, Molchan S, Sunderland T, Wolkowitz O. Weingartner H, et al. Psychopharmacol Bull. 1992;28(4):331-40. Psychopharmacol Bull. 1992. PMID: 1296214 Review.

4

A single oral dose challenge of buspirone does not affect memory processes in older volunteers.

Lawlor BA, Hill JL, Radcliffe JL, Minichiello M, Molchan SE, Sunderland T. Lawlor BA, et al. Among authors: molchan se. Biol Psychiatry. 1992 Jul 1;32(1):101-3. doi: 10.1016/0006-3223(92)90147-r. Biol Psychiatry. 1992. PMID: 1391290 Clinical Trial. No abstract available.

5

Distribution of peripheral lymphocytes in Alzheimer patients and controls.

Dysken MW, Minichiello MD, Hill JL, Skare S, Little JT, Molchan SE, Sunderland T. Dysken MW, et al. Among authors: molchan se. J Psychiatr Res. 1992 Jul;26(3):213-8. doi: 10.1016/0022-3956(92)90024-i. J Psychiatr Res. 1992. PMID: 1432847

6

Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model.

Molchan SE, Martinez RA, Hill JL, Weingartner HJ, Thompson K, Vitiello B, Sunderland T. Molchan SE, et al. Brain Res Brain Res Rev. 1992 Sep-Dec;17(3):215-26. doi: 10.1016/0165-0173(92)90017-g. Brain Res Brain Res Rev. 1992. PMID: 1467811 Clinical Trial.

7

The dexamethasone suppression test in Alzheimer's disease and major depression: relationship to dementia severity, depression, and CSF monoamines.

Molchan SE, Hill JL, Mellow AM, Lawlor BA, Martinez R, Sunderland T. Molchan SE, et al. Int Psychogeriatr. 1990 Fall;2(2):99-122. doi: 10.1017/s1041610290000370. Int Psychogeriatr. 1990. PMID: 1713799 Review.

8

CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.

Molchan SE, Lawlor BA, Hill JL, Martinez RA, Davis CL, Mellow AM, Rubinow DR, Sunderland T. Molchan SE, et al. Biol Psychiatry. 1991 Jun 1;29(11):1110-8. doi: 10.1016/0006-3223(91)90253-i. Biol Psychiatry. 1991. PMID: 1714776 Free article.

9

Lack of seasonal variation in the births of patients with dementia of the Alzheimer type.

Vitiello B, Hill JL, Molchan SE, Martinez RA, Martinson HJ, Sunderland T. Vitiello B, et al. Among authors: molchan se. Psychiatry Res. 1991 Oct;39(1):21-4. doi: 10.1016/0165-1781(91)90004-9. Psychiatry Res. 1991. PMID: 1771206

10

Reciprocal changes in psychosis and mood after physostigmine in a patient with Alzheimer's disease.

Molchan SE, Vitiello B, Minichiello M, Sunderland T. Molchan SE, et al. Arch Gen Psychiatry. 1991 Dec;48(12):1113-4. doi: 10.1001/archpsyc.1991.01810360077011. Arch Gen Psychiatry. 1991. PMID: 1845230 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters